MNOV: FDA Gives OK to Initiate Clinical Trial of MN-166 to Prevent ARDS in COVID-19 Patients
Zacks Small Cap Research · 07/02 10:47
FDX, BYND among premarket gainers
Seeking Alpha - Article · 07/01 12:11
MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) for Prevention of Acute Respiratory Distress Syndrome in Patients with COVID-19
GlobeNewswire · 07/01 11:30
MediciNova on go with study of MN-166 in COVID-19
Seeking Alpha - Article · 07/01 10:51
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
Benzinga · 06/26 13:28
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 25)
Benzinga · 06/26 12:28
INO, DVAX among premarket gainers
Seeking Alpha - Article · 06/26 12:21
MediciNova +14% on encouraging ibudilast data in glioblastoma